University of Washington

School of Pharmacy 2013 Excellence Report

Issue link: http://uwashington.uberflip.com/i/102670

Contents of this Issue

Navigation

Page 4 of 19

Grants Abbreviated Project Title Funding Agency Direct Cost Fiscal Year 2012 PI Multiyear Total, if Applicable* Pharm Optimization NIH $501,734 Anderson $2,594,290 PGP Mechs NIH $219,000 Atkins $880,685 LSDF BioE Center WA Life Sciences Discovery Fund $258,028 Atkins and Catalano $980,778 Various Projects Fred Hutchinson Cancer Research Center (FHCRC) $33,469 Blough HIV Env Trimer Spikes NIH $160,232 Catalano $273,750 Lambda Capsid National Science Foundation $194,382 Catalano $717,700 Viral DNA NIH (U Cal San Diego subcontract) $189,706 Catalano $348,161 Andrews F32 Fellowship NIH $53,942 Catalano $152,874 CERTN EDM Paper AcademyHealth/AHRQ - ARRA $7,500 Devine Fellowship Allergan Inc. $75,046 Devine $134,939 Comparative Effec Rsch PhRMA Foundation $125,000 Garrison $250,000 Pfizer Fellowship 3 Pfizer Inc. $115,736 Garrison $223,521 Bedalov Biomarkers Sub NIH (FHCRC subcontract) $8,123 Goodlett Artemisinin Compounds WA Life Sciences Discovery Fund $87,883 Goodlett $258,527 g2AMPK NIH $34,102 Goodlett $183,787 Morrison P30 (Core B) NIH $175,846 Goodlett $688,567 NWRCE (RCE CORE D Y9) NIH $103,855 Goodlett $519,773 Anticholinergic Med Group Health Research Institute $18,807 Gray $93,491 UW-Obstetric Fetal Pharmacology RU NIH NICHD $515,550 Hebert $3,250,000 pH-CD4-DDS NIH $586,292 Ho $2,226,630 MIP HIV NIH NIAID (U Utah subcontract) $204,590 Ho $1,061,619  Oral HIV vaccines NIH $277,789 Hu $2,032,927 HIV-1 Drug Resistance NIH NIAID (U Pittsburgh subcontract) $181,563 Hu $393,620 Pinter HIVRAD Prj 3 NIH PHRI (U of Med & Dentistry of NJ subcontract) $389,050 Hu $2,307,180 Hu-IPS st-HIV-1 Institut Pasteur of Shanghai-Chinese Acad Sciences $143,768 Hu Modulation of receptor NIH NIAID (U Mass Medical School subcontract) $518,457 Hu $2,054,979 Clade C Core NIH (Dana-Farber Cancer Institute subcontract) $120,652 Hu $1,069,773 Core A – NHP Model NIAID (FHCRC subcontract) $587,986 Hu $3,030,628 Unmasking HIV Epitopes Bill & Melinda Gates Foundation $5,175,945 Hu $6,269,066 Xenobiotics NIH $186,219 Isoherranen $933,664 Flu Fusion NIH $190,000 Lee $950,000 Structure of HIV Env NIH CFAR (U Alabama Birmingham subcontract) $150,000 Lee $207,789 Crucell Assays Crucell Holland B.V. $6,800 Lee Guttman F32 Fellowship NIH $49,214 Lee $101,404 Pediatric CYP2D6 NIH (Children's Mercy Hosp, Kansas City subcontract) $160,066 Lin $524,287 Pharmacogenetics NIH $250,521 McCune $501,543 Staff assignment FHCRC $24,416 McCune UNCF/Merck – Hardy United Negro College Fund $90,000 Nelson Plankton NSF (Georgia Inst of Tech subcontract) $31,495 Nunn HSR and D Project – VA US Dept of Veterans Affairs $11,700 Odegard Drug Metabolism Training Grant NIH $566,295 Rettie $2,828,769 Drug Interactions NIH $937,696 Rettie $4,672,107 Bastyr/UW Oncomycology NIH $18,159 Shen $46,159 PCOR K12 NIH/AHRQ $417,820 Sullivan $1,160,883 Variations in Health Merck and Co. Inc. $148,521 Sullivan Pharmacogenetics NIH/NIGMS $2,307,604 Thummel $8,053,777 Role of CYP2J2 NIH $222,750 Totah $1,118,250 UW Research Affil Prg Transporters AstraZeneca LP/Genentech Inc./Merck $240,000 Unadkat CANCERGEN Y2 NIH (FHCRC subcontract) – ARRA $351,881 Veenstra GHC SA 2 NIH/Group Health $29,196 Veenstra TOTAL: $17,454,386 TOTAL: $94,511 $51,609,016 *Multiyear totals on subcontract grants are estimated based on current year funding. [ 2013 Excellence Report 3 ]

Articles in this issue

view archives of University of Washington - School of Pharmacy 2013 Excellence Report